45th Annual Summer Meeting—Detailed Agenda 

Program Planning Committee Members

   

Jamie DeWitt, East Carolina University (Chair)
Brian Hughes, NSF International (Co-Chair)
Joanne Birkebak, Gilead
Sarah Blossom, University of Arkansas for Medical Sciences
Grace Chappell, ToxStrategies, Inc.
Laurie Dolan, US FDA/CFSAN
Jeanne Domoradzki, Corteva Agriscience
Maia Green, ExxonMobil Biomedical Sciences, Inc.
Barry McIntyre, NIEHS-NTP
Edward Ohanian, US EPA/OW (Board Liaison)
Santhini Ramasamy, US EPA/NCEA
Amy Roe, Procter & Gamble Company

 

Detailed Program Schedule By Day

 

 

Monday, July 8

 

8:00 AM–10:00 AM

SESSION: Communicating Complex Toxicological Science to Diverse Audiences

Moderator: Katlyn May, Center for Human Health and the Environment at North Carolina State University

8:00 AM–8:20 AM

Creating a Dialogue to Educate Legislators about Timely Scientific Problems: A State Perspective

Jeff Warren, North Carolina Policy Collaboratory

8:20 AM–8:40 AM

Chemical Hazards on Military Bases: Communicating Laboratory Science to Potentially Exposed Military Personnel

Sarah Blossom, Arkansas Children's Research Institute

8:40 AM–9:00 AM

Inspiring the Public to Learn about Toxicology: How the Voice of Journalism Is a Tool for Public Health Education

Vaughn Hagerty, Freelance Journalist

9:00 AM–9:20 AM

Communicating and Translating the US EPA’s Science to Diverse Stakeholder Groups from the Scientific Community to the General Public

Monica Linnenbrink, US EPA/NCCT

9:20 AM–10:00 AM

Moderated Panel and Attendee Discussion

10:00 AM–10:30 AM

Scientific Program Break—Attendee Small Group Discussion

10:30 AM–12:30 PM

SESSION: Should Fluoropolymers, Polymeric PFAS Meeting OECD Polymer of Low-Concern (PLC) Criteria, Be Grouped with All PFAS for Regulatory Purposes?

Moderated by Barbara Henry, W.L. Gore & Associates

10:30 AM–10:55 AM

What Differentiates Polymers from Non-polymers and Fluoropolymers from Other Polymers? 

Sina Ebnesajjad, FluoroConsultants Group, LLC

10:55 AM–11:20 AM

Why Data Packages for Polymers and Non-polymers Differ and Are Not “Data Gaps” 

Margaret Whittaker, ToxServices, LLC

11:20 AM–11:45 AM

What Are the Appropriate Physiochemical Properties to Identify Polymers of Concern (PoC)?  

Jeffrey Hafer, knoell USA

11:45 AM–12:10 PM

Fluoropolymers Are the Exceptional PFAS Class, Distinctly Different from the Other Four PFAS Classes and Should Be Excluded from Grouping of PFAS Classes for Management Actions  

Barbara Henry, W.L. Gore & Associates

12:10 PM–12:30 PM

Moderated Panel and Attendee Discussion

12:30 PM–1:30 PM

Attendee Luncheon
(Included with Registration)

1:30 PM–5:00 PM

SESSION: Threshold-Based Cancer Risk Assessment for Carcinogens: Inorganic Arsenic as a Case Study

Moderator: Samuel Cohen, University of Nebraska Medical Center

1:30 PM–2:00 PM

Mode-of-Action for Inorganic Arsenic-Induced Cancer and Evaluation of Animal Studies

Samuel Cohen, University of Nebraska Medical Center

2:00 PM–2:30 PM

In Vitro Investigations of Inorganic Arsenic and Calculation of Estimated Threshold in Humans Based on Non-epidemiology Data

Harvey Clewell, Ramboll US Corp

2:30 PM–3:00 PM

Epidemiology of Cancer and Inorganic Arsenic in Drinking Water and the Basis for Estimated Threshold of 100 µg/L

Ellen Chang, Exponent, Inc

3:00 PM–3:30 PM

Scientific Program Break—Attendee Small Group Discussion

3:30 PM–4:00 PM

Implications of the Threshold Approach for Food Safety Evaluation

Rosalind Schoof, Ramboll US Corp

4:00 PM–4:30 PM

Implications of the Threshold Approach for Environmental Risk Assessment for Inorganic Arsenic in the Drinking Water

Sabine Lange, Texas Commission on Environmental Quality

4:30 PM–5:00 PM

Moderated Panel and Attendee Discussion

All speakers with additional panelist;
Evisabel Craig, US EPA/OPP

5:45 PM–7:00 PM Welcome Reception

 

Tuesday, July 9

 

8:00 AM–11:30 AM

SESSION: Are US vs. EU Differences in Regulatory Framework for Developmental Thyroid and Neurotoxicity Testing Triggering Unnecessary Testing and Labeling?

Speaker Question Moderators: Jeanne Domoradzki, Corteva Agriscience; and Abby Li, Exponent, Inc.

Panel Discussion Moderators: Elizabeth Mendez, US EPA/OPP; and Simon Warren, UK Office, Exponent International Limited

8:00 AM–8:20 AM

US and EU Regulatory Conundrums and Technical Challenges

Abby Li, Exponent, Inc.

Industry Survey

Jeanne Domoradzki, Corteva Agriscience

8:20 AM–8:45 AM

The EU E(ndocrine)-Factor Impact on Developmental Thyroid (DTT) and Related (Neuro)toxicity Testing, Hazard Assessment, and Labeling

Simon Warren, UK Office, Exponent International Limited

8:45 AM–9:15 AM

Thyroid Hormone Triggers: Why DTT and Not DNT?

Mary Gilbert, US EPA/NHEERL

9:15 AM–9:45 AM

Are All Thyroid Hormone Changes Adverse? Case for Consideration of DNT to Interpret DTT—Regulatory Issues

Sue Marty, Dow Chemical Company, US

9:45 AM–10:15 AM

Tales from the Trenches: Implementing New ECHA/EFSA Guidance on Mode-of-Action of Thyroid-Disruption and on the Weight of Evidence for Human Relevance

Remi Bars, Bayer SAS, France

10:15 AM–10:45 AM Scientific Program Break—Attendee Small Group Discussion
10:45 AM–11:30 AM

Moderated Panel and Attendee Discussion

Includes all invited speakers

11:30 AM–12:00 Noon

George H. Scott Memorial Award Lecture

Awardee: Susan Felter, Procter & Gamble Company

12:00 Noon–12:30 PM

Toxicology Forum Annual Business Meeting

All Attendees Welcome

12:30 PM–1:30 PM Attendee Luncheon
(Included with registration)
1:30 PM–2:00 PM

UPDATE PRESENTATION: Per- and Poly-fluoroalkyl Substances (PFAS): A Lifecycle Perspective

Jamie DeWitt, East Carolina University, Brody School of Medicine

This presentation is supported through the David Miller Award Funds.

2:00 PM–2:30 PM

UPDATE PRESENTATION: The Key Characteristics of Carcinogens Concept Is Now Incorporated into the International Agency for Cancer Research’s (IARC) Preamble: Implications

Jay Goodman, Michigan State University

This presentation is supported through the David Miller Award Funds.

2:30 PM–5:00 PM

The Gut Microbiome: Impact on Metabolism of Drugs, Dietary Contaminants and Health

Moderator: Cody Wilson, The Coca-Cola Company

This session is supported through the David Miller Award Funds.

2:30 PM–3:00 PM

The Myriad Interactions of Drugs with Gut Bacterial Beta-Glucuronidases

Sam Pellock, University of North Carolina at Chapel Hill

3:00 PM–3:30 PM Scientific Program Break—Attendee Small Group Discussion
3:30 PM–4:00 PM

Dietary Exposures: Role of the Microbiome in Influencing the Effect of Environmental Compounds on Gut Health

Clint Allred, Texas A&M University

4:00 PM–4:30 PM

Observations and Challenges in Deciphering Study to Study Results of Microbiome Analysis in Toxicological Risk Assessment of Xenobiotic Residues in Food

Carl Cerniglia, US FDA/NCTR

4:30 PM–5:00 PM

Moderated Panel and Attendee Discussion

All speakers with additional panelist;
Paul Carlson, US FDA/CBER

6:00 PM–7:00 PM Attendee Reception
(Included with Registration) 

 

Wednesday, July 10

 

8:00 AM–10:00 AM

SESSION: Collaboration Is Key: Predictive Computational Models for Acute Systemic Toxicity

Moderated by Esther Haugabrooks, Physician's Council for Responsible Medicine

8:00 AM–8:30 AM

Implementation of Nonanimal Approaches for Acute Systemic Toxicity

Grace Patlewicz, US EPA/NCCT

8:30 AM–9:00 AM

Collaborative Computational Efforts to Predict Acute Oral Toxicity 

Kamel Mansouri, ILS

9:00 AM–9:30 AM

A Cross-Industry Effort to Develop Protocols for In Silico Approaches for Acute Dose Toxicity: The Food Safety Perspective

Elena Lo Piparo, Nestle

9:30 AM–10:00 AM

Moderated Panel and Attendee Discussion

10:00 AM–10:30 AM Scientific Program Break—Attendee Small Group Discussion
10:30 AM–2:00 PM

SESSION: Build the Confidence to Protect Human Health without the Cancer Bioassay

Moderated by June Yan, Corteva Agriscience

10:30 AM–11:00 AM

Alternatives for Rodent Carcinogenicity Study: Pharmaceutical Perspectives

Frank Sistare, Merck & Co., Inc.

11:00 AM–11:30 AM

The Two-Year Bioassay Is No Longer Necessary: Liver and Urinary Bladder as Examples

Samuel Cohen, University of Nebraska Medical Center

11:30 AM–12:00 Noon

Utilizing Gene Set Enrichment Analysis to Analyze Toxicogenomic Data for Use in Human Health Risk Assessment

Jeffrey Dean, US EPA/NCEA

12:00 Noon–12:30 PM Scientific Program Break—Attendee Small Group Discussion
12:30 PM–1:00 PM

Alternative Methods for Cosmetics Testing: Personal Care Industry

Susan Felter, Procter & Gamble Company

1:00 PM–1:30 PM

The Future of Agrochemical Risk Assessment: Framework for Conducting Chronic Risk Assessment with Enhanced Short-Term Toxicological Studies and Significantly Reduced Residue Trial Studies

June Yan, Corteva Agriscience

1:30 PM–2:00 PM

Moderated Panel and Attendee Discussion

All speakers with additional panelist;
Todd Bourcier, US FDA/CDER